Investing
587 Articles
As of late last week we had many potentially imminent buyouts that could have hit the market. When we were…
Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the…
Markets opened a few ticks lower this morning after a poor report on new claims for unemployment benefits in the…
Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to…
Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…
The data is from a major union, and, therefore, may have a bias against chief executives. Numbers can be bent.The…
After legal issues slowed their progress last year, foreclosures are about to increase. (Reuters)Time Warner Cable (NYSE: TWC) may end…
If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN). …
Anheuser-Busch InBev NV may buy China’s Kingway Brewery Holdings’ assets. (Reuters)The Department of Justice is expected to widen its probe of mortgage-backed securities.…
Gilead Sciences, Inc. (NASDAQ: GILD) has recovered from its pre-market lows on the devastating news that its Hepatitis C drug…
The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. …
All three major US indexes opened higher this morning, but enthusiasm tapered off quickly and steadily, if not sharply. A…
Our top personal finance-related articles today. Your wallet will thank you later.